17-44207332-CTCG-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_014233.4(UBTF):βc.2202_2204delβ(p.Asp734del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000362 in 1,612,538 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.00055 ( 0 hom., cov: 30)
Exomes π: 0.00034 ( 0 hom. )
Consequence
UBTF
NM_014233.4 inframe_deletion
NM_014233.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.02
Genes affected
UBTF (HGNC:12511): (upstream binding transcription factor) This gene encodes a member of the HMG-box DNA-binding protein family. The encoded protein plays a critical role in ribosomal RNA transcription as a key component of the pre-initiation complex, mediating the recruitment of RNA polymerase I to rDNA promoter regions. The encoded protein may also play important roles in chromatin remodeling and pre-rRNA processing, and its activity is regulated by both phosphorylation and acetylation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. Pseudogenes of this gene are located on the short arm of chromosomes 3, 11 and X and the long arm of chromosome 11. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 17-44207332-CTCG-C is Benign according to our data. Variant chr17-44207332-CTCG-C is described in ClinVar as [Benign]. Clinvar id is 2243923.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 84 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBTF | NM_014233.4 | c.2202_2204del | p.Asp734del | inframe_deletion | 21/21 | ENST00000436088.6 | NP_055048.1 | |
ATXN7L3-AS1 | NR_184071.1 | n.91+8411_91+8413del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBTF | ENST00000436088.6 | c.2202_2204del | p.Asp734del | inframe_deletion | 21/21 | 2 | NM_014233.4 | ENSP00000390669 | P1 | |
ATXN7L3-AS1 | ENST00000586560.1 | n.53+8407_53+8409del | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000553 AC: 84AN: 152020Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
84
AN:
152020
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000478 AC: 118AN: 246648Hom.: 0 AF XY: 0.000420 AC XY: 56AN XY: 133334
GnomAD3 exomes
AF:
AC:
118
AN:
246648
Hom.:
AF XY:
AC XY:
56
AN XY:
133334
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000342 AC: 500AN: 1460400Hom.: 0 AF XY: 0.000339 AC XY: 246AN XY: 726358
GnomAD4 exome
AF:
AC:
500
AN:
1460400
Hom.:
AF XY:
AC XY:
246
AN XY:
726358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000552 AC: 84AN: 152138Hom.: 0 Cov.: 30 AF XY: 0.000578 AC XY: 43AN XY: 74384
GnomAD4 genome
AF:
AC:
84
AN:
152138
Hom.:
Cov.:
30
AF XY:
AC XY:
43
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at